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Abstract. Aim: To assess endothelial progenitor cells (EPC) counts, a novel prognostic marker, in relation to classical adverse
outcome predictors – N-terminal pro–B-type natriuretic peptide (NT-proBNP), impaired left ventricular (LV) relaxation and
exercise-induced ischemia – in stable coronary artery disease (CAD) with preserved LV systolic function.
Methods: We studied 30 non-diabetic men with one-vessel CAD, LV ejection fraction  60% and normal LV diastolic function
(n = 16) or impaired LV relaxation (by ultrasound including tissue Doppler) (n = 14), and 14 non-CAD controls matched for risk
profile and medication. CD34+/kinase-insert domain receptor (KDR)+ cells (CD34+/KDR+ cells), a leukocytes subpopulation
enriched for EPC, were enumerated by flow cytometry.
Results: CAD patients with abnormal LV relaxation exhibited significantly elevated NT-proBNP and decreased CD34+/KDR+
cells vs. CAD with regular diastolic function and non-CAD controls. An inverse NT-proBNP–CD34+/KDR+ cells relationship
was precipitated by the clustering of high resting NT-proBNP and low CD34+/KDR+ cells in the subjects with a lower Duke
treadmill score.
Conclusions: Propensity to symptomatic exertional ischemia may underlie the coincidence of moderately elevated NT-proBNP
and EPC deficiency in stable angina. Additionally, chronic subclinical ischemia can also be involved in these associations. These
might result from BNP overexpression in the ischemic myocardium and a hypothetical exhaustion of the bone marrow capacity
to mobilize EPC at multiple ischemic episodes, thus contributing to NT-proBNP prognostic effect irrespective of hemodynamic
factors.
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1. Introduction
Elevated circulating levels of B-type natriuretic pep-
tide (BNP) or N-terminal fragment of its prohormone
(NT-proBNP) are adverse outcome predictors not only
in heart failure and acute coronary syndromes but also
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in stable coronary artery disease (CAD) [1–6]. The
prognostic effect of BNP/NT-proBNP in stable CAD
was maintained after multivariate adjustment including
ejection fraction (EF), angiographic CAD extent, renal
function, left ventricular (LV) end-diastolic pressure
(LVEDP) and echocardiographiccategories of diastolic
dysfunction [1–6], which suggests that the effect ex-
tends also into low-risk subjects with discrete or absent
LV function abnormalities. An excessive cardiovascu-
lar mortality risk was reported already at NT-proBNP
levels over 67–120 pg/ml by an electrochemilumines-
cence immunoassay [1,2,5,6], i.e. close to upper limits
of the normal range [7] and similar to those proposed in
the diagnostics of isolated diastolic dysfunction or heart
failure [8,9]. In patients with preserved EF moderate
elevations of B-type natriuretic peptides were described
in parallel to the degree of LV diastolic dysfunction
with about 6-fold and 3-fold increases in BNP and NT-
proBNP, respectively, in the earliest phase of diastolic
abnormalities, equivalent to impaired LV relaxation [8,
10]. Furthermore, BNP gene is overexpressed in the
hypoxic myocardium [11].
In the presence of a flow-limiting coronary steno-
sis impaired relaxation results from abnormal calcium
handling in cardiomyocytes that predominantly affects
the subendocardium [12]. Pritchett et al. [13] observed
an independent rise in all-cause mortality in the pres-
ence of abnormal LV relaxation (i.e. mild diastolic dys-
function) by classical indices of transmitral and pul-
monary flow in a population-based study of 2,042 resi-
dents  45 years of age over a 6-year follow-up. With
regard to cardiac death, Wang et al. [14] have shown
incremental prognostic value of an index of LV relax-
ation derived from tissue Doppler imaging (TDI) com-
pared to clinical data and variables based on mitral in-
flow velocities in 518 subjects (including 353 patients
with various cardiac diseases) over a 2-year follow-
up. This index of long axis LV function, peak early
lengthening velocity at the junction of the LV wall with
the mitral annulus (E’), represents a relatively preload-
independent measure of relaxation and is governed by
longitudinally oriented subendocardial fibers [15,16].
Lee et al. [17] reported that TDI indices of diastolic
function (but not parameters derived from transmitral
flow) were related to biochemical measures of endothe-
lial dysfunction and platelet activation independently
of LV systolic function in stable angina patients free of
heart failure.
Endothelial dysfunction, another predictor of ad-
verse outcome in CAD [18], coincides with deficiency
of bone marrow-derived blood endothelial progenitor
cells (EPC) in subjects with atherosclerotic risk fac-
tors [19] and in CAD [20]. EPC are supposed to par-
ticipate in endothelial renewal [21,22] and neovascu-
larization of ischemic tissues [23]. Furthermore, de-
pletion of circulating CD34/kinase-insert domain re-
ceptor (KDR)-double positive cells (a leukocytes sub-
population enriched for EPC) (CD34+/KDR+ cells) is
considered, like BNP, an adverse outcome predictor in
CAD [24,25].
We hypothesized that a lower CD34+/KDR+ cells
count might appear already in patients with stable angi-
na and impaired LV relaxation thus contributing to the
prognostic effect of moderately elevated concentrations
of BNP/NT-proBNP. On the other hand, as a single
episode of exercise-dependent myocardial ischemia in-
duced a persistent (up to 48 h) mobilization of EPC [26],
patients with repetitive ischemic episodes could exhibit
rather a sustained rise in CD34+/KDR+ cells numbers
in addition to an elevated NT-proBNP level.
Therefore our aim was to investigate blood CD34+/
KDR+ cells counts in relation to classical adverse out-
come predictors: plasma NT-proBNP levels, impaired
LV relaxation pattern and exercise-induced ischemia
in a relatively homogenous group of non-diabetic men
with stable angina, one-vessel CAD and preserved LV
function.
2. Materials and methods
2.1. Subjects
We studied 2 groups of patients undergoing planned
diagnostic coronary angiography in our center. The
CAD group was formed by 30 men who fulfilled all four
of the following inclusion criteria: stable angina class
III according to the Canadian Cardiovascular Society
(CCS) classification, angiographically significant one-
vessel CAD, classical ECG signs of subendocardial
myocardial ischemia during an exercise test [27], and
an unchanged therapy with a low-dose aspirin, statin
and angiotensin-converting enzyme inhibitor (ACEI)
for 3 preceding months. Angiographically significant
CAD was defined as the presence of at least 1 diameter
stenosis of  70% within major epicardial segments
of one of coronary arteries according to the Ameri-
can College of Cardiology/American Heart Association
(ACC/AHA) guidelines on the management of patients
with chronic stable angina [28].
The control non-CAD group consisted of 14 men
without coronary narrowings exceeding 20%, matched
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for age, BMI, GFR and other risk factors and receiv-
ing a similar medication. In the controls coronary an-
giography was performed due to atypical angina and an
inconclusive exercise testing result.
Out of potentially eligible 115 pre-screened pa-
tients, 71 had been eliminated by a wide set of the
exclusion criteria that included age below 40 or over
70 years, a history of heart failure, acute coronary
syndromes, percutaneous or operative coronary revas-
cularization, diabetes mellitus, chronic kidney dis-
ease (estimated glomerular filtration rate (GFR) below
60 ml/min/1.73 m2 as calculated according to the sim-
plified Modification of Diet in Renal Disease study
equation), atrial fibrillation or flutter, arterial hyperten-
sion uncontrolled adequately by drugs, hemoglobin <
11 g/dl, thrombocytopenia (< 105/µl), chronic obstruc-
tive pulmonary disease, pulmonary embolism, abnor-
malities of thyroid or liver function, malignant or in-
flammatory diseases, any surgery within past 6 months,
any infections within past 2 months, chronic non-
cardiovascular medication.
Additionally, we had excluded subjects with pericar-
dial disease, significant valvular heart disease, congeni-
tal heart disease, abnormal LV diameters, segmental LV
wall-motion abnormalities, EF below 60% (according
to a modified biplane Simpson’s method from apical 2-
and 4-chamber views), LV hypertrophy (defined as LV
mass index (LVMI) over 125 g/m2 calculated accord-
ing to Devereux formula) [29], and echocardiographic
patterns of LV diastolic dysfunction other than its mild
form, i.e. impaired LV relaxation.
2.2. Echocardiographic assessment of LV diastolic
function
During a routine cardiac ultrasound (Vivid 7 , GE
Healthcare Medical Diagnostics, Little Chalfont, UK)
the impaired relaxation pattern was identified using a
two-step approach proposed by Tschöpe et al. [30]. A
preliminary condition was the presence of at least two
abnormal indices of transmitral flow: isovolumic LV
relaxation time (IVRT) > 100 ms, deceleration time
(DT) of mitral E wave > 220 ms, or E/A ratio < 1.0
for subjects below 50 years of age. Respective cut-off
values for those aged  50 years were IVRT > 105 ms,
DT > 280 ms and E/A < 0.5 [9,31]. Then impaired
LV relaxation was confirmed by TDI indices measured
at the junction of the LV lateral wall with the mitral an-
nulus: peak early myocardial lengthening velocity (E’)
< 8 cm/s and the ratio of early-to-late peak diastolic
myocardial lengthening velocities (E’/A’) below 1.0 [8,
32]. Normal LV diastolic function was defined as E/A
= 1.0–2.0. IVRT = 60–100 ms for age < 50 years
(60–105 ms for age  50 years) ms, DT = 150–210
(240) ms, E’ > 8 cm/s and E’/A’ > 1.0 irrespective of
age [8,32].
In order to exclude more advanced stages of diastolic
dysfunction (i.e. moderate or severe dysfunction asso-
ciated with elevated LV diastolic pressures) or confirm
normal LV diastolic function, E/E’ ratio was calculat-
ed and flow pattern in the right upper paraseptal pul-
monary vein was studied. All the patients – irrespective
of the presence of the impaired relaxation pattern – had
to exhibit an E/E’ < 15, systolic-dominant pulmonary
venous flow, peak velocity of the pulmonary venous
atrial reversal wave < 35 cm/s, the difference between
pulmonary venous atrial reversal duration and mitral A
wave duration below 30 ms [8,9,16,32,33] and left atri-
al volume index (LAVI) at ventricular end-systole cal-
culated from parasternal long-axis view and the apical
4-chamber view [8,13,34] below 29 ml/m 2 [13].
2.3. ECG exercise testing
A treadmill symptom-limited ECG exercise test ac-
cording to the Bruce protocol was performed in all CAD
subjects in agreement with the ACC/AHA standards as
a part of the routine diagnostic procedure [27]. Patients
with resting ECG abnormalities that would make ECG
changes on exercise non-interpretablehad been a priori
excluded. Reasons for exercise termination was severe
dyspnea, fatigue, limiting angina, a decrease in systolic
blood pressure of > 10 mmHg or a ST segment depres-
sion of  0.3 mV. In no case was the test terminated
due to a ST segment elevation of > 0.1 mV, serious
arrhythmias, bundle-branch block, an excessive hyper-
tensive response or central nervous system symptoms.
The following parameters were computed: exercise du-
ration, maximal workload achieved (metabolic equiva-
lents, METs), maximal horizontal or downsloping ST
segment depression in any lead during exercise or 6
min of recovery (measured in 3 consecutive beats with
a stable baseline at 60–80 ms after the J point relative to
the PQ junction and minus resting changes) [27], time
to onset of a 0.1-mV horizontal or downsloping ST seg-
ment depression, and Duke treadmill score. The Duke
treadmill score integrates exercise duration, maximal
ST segment depression in any lead and presence and
type of angina during the test [35].
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2.4. Blood collection
The Bioethical Committee of our university has ap-
proved the protocol and the patients gave informed
consent. Fasting venous blood samples for assay of
CD34+/KDR+ cells were drawn after an overnight
fast on the occasion of routine blood sampling 0–2
days prior to a planned coronary angiography and 1–2
days after echocardiography. Simultaneously, plasma
was separated and samples frozen at −70◦C until fur-
ther measurements of NT-proBNP, vascular endothelial
growth factor (VEGF) and high-sensitivity C-reactive
protein levels.
2.5. Flow cytometric analysis
The procedure was performed < 60 min from the
venopuncture as previously described [24,25,36,37]. In
brief, 100 µl of blood was incubated in the dark with
mouse monoclonal antibodies against human VEGF
receptor type 2 (KDR) (Sigma, St. Louis, MO, USA)
followed by rabbit fluoroscein isothiocyanate (FITC)-
labeled secondary antibodies (Dako, Glostrup, Den-
mark) and phycoerythrin (PE)-conjugated mouse mon-
oclonal antibodies against human CD34 (Becton Dick-
inson, Franklin Lakes, NJ, USA). Control blood sam-
ples were incubated with mouse isotype-matched anti-
bodies (IgG1-FITC and IgG2a-PE, γ-Simultest, Becton
Dickinson). After lysis of erythrocytes, flow cytomet-
ric analysis was performed including 100,000 cytomet-
ric events (FACScan, Becton Dickinson GmbH, Hei-
delberg, Germany). EPC were defined as CD34/KDR-
double positive cells and their number was expressed
as a percentage of peripheral blood mononuclear cells
(PBMC) within the pre-specified lymphocyte gate [20,
24,25,36,37].
2.6. Assay for NT-proBNP, VEGF and high-sensitivity
C-reactive protein
NT-proBNP and VEGF were measured with com-
mercially available immunoassays (Elecsys proBNP,
Roche Diagnostics GmbH, Mannheim, Germany, and
R&D Systems, Minneapolis, MN, USA, respectively).
According to the manufacturers’ instructions, the low-
er detection limit for both analytes was 5.0 pg/ml and
intra-assay and inter-assay coefficients of variation <
4% (NT-proBNP) and < 9% (VEGF). High-sensitivity
C-reactive protein was estimated by a chemilumines-
cent immunoassay system (Immulite 1000, DPC, Flan-
ders, NJ, USA).
2.7. Statistical analysis
Data are presented as means ± standard deviations
(SD) for variables with normal distribution, medians
and interquartile ranges (25th and 75th percentiles) for
not normally distributed continuous parameters (NT-
proBNP levels, CD34+/KDR+ cells counts and high-
sensitivity C-reactive protein concentrations) and num-
bers (percentages) for categorical variables. Compar-
isons of the not normally distributed variables between
3 groups – CAD with abnormal LV relaxation, CAD
with regular LV diastolic function and non-CAD con-
trols – were performed by the Kruskal-Wallis analysis
of variance (ANOVA) on ranks followed by the Mann-
Whitney U test for pairwise analyses. Intergroup com-
parisons of the remaining continuous variables were
done by one-way ANOVA and the Tukey’s honest sig-
nificant difference post-hoc tests, whereas categorical
variables were assessed by the Fisher’s 2-sided exact
test. Exercise testing results and angiographic data be-
tween 2 subgroups of CAD subjects were compared by
the unpaired Student’s 2-sided t-test or the Fisher’s test
for proportions.
In order to identify correlates of NT-proBNP levels
and CD34+/KDR+ cells numbers, Spearman’s rank
order correlation coefficients (rho) were calculated sep-
arately for CAD patients and non-CAD controls. Pear-
son’s correlation coefficients (r) were used after pri-
or logarithmic data transformation to obtain a normal
distribution. Independent determinants of logarithmic
derivatives of NT-proBNP levels and CD34+/KDR+
cells counts in CAD subjects were selected by means
of backward stepwise multiple regression with a ridge
regression approach to control for mutual correlations
between parameters obtained from ECG exercise test-
ing and echocardiography. Only correlates of log (NT-
proBNP) or log (CD34+/KDR+ cells count) with a
p-value  0.15 at univariate analysis were included in
preliminary sets of potential covariates in the multiple
regression Adjusted coefficients of multiple determi-
nation (R2) and standard mean regression coefficients
(β ± SEM) for individual variables entering the final
regression equations were shown. A p-value  0.05
was considered statistically significant.
3. Results
3.1. Patient characteristics – clinical, biochemical,
angiographic, echocardiographic parameters
and exercise testing results
There were no significant differences between 3
groups in clinical, biochemical and angiographic char-
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Table 1
Patient characteristics – clinical and biochemical data
Non-CAD CAD CAD p
controls normal diastolic impaired
(n = 14) LV function LV relaxation
(n = 16) (n = 14)
Age (years) 57 ± 10 56 ± 8 56 ± 9 NS
BMI (kg/m2) 27.0 ± 3.5 26.6 ± 3.4 27.0 ± 3.1 NS
GFR (ml/min/1.73 m2) 90 ± 16 92 ± 14 94 ± 15 NS
Smoking habit (%) 6 (43) 7 (44) 7 (50) NS
Hypertension (%) 5 (36) 5 (31) 5 (36) NS
Blood pressure (mmHg) 93 ± 9 92 ± 10 94 ± 11 NS
Heart rate (beats/min) 67 ± 7 64 ± 8 65 ± 7 NS
LDL cholesterol (mmol/l) 2.8 ± 0.8 2.9 ± 0.8 2.7 ± 0.9 NS
Fasting glucose (mmol/l) 4.8 ± 0.7 4.7 ± 0.8 4.7 ± 0.9 NS
C-reactive protein (mg/l) 1.7 (0.9–2.9) 1.9 (0.8–3.4) 1.8 (0.9–3.5) NS
VEGF (pg/ml) 16 ± 10 19 ± 11 17 ± 12 NS
Drugs besides AA+ACEI+statins
Long-acting nitrates (%) 12 (86) 15 (94) 13 (93) NS
Beta-blockers (%) 12 (86) 13 (81) 13 (93) NS
Calcium channel blockers (%) 5 (36) 5 (31) 6 (43) NS
Data are shown as means ± SD, n (%) and medians (interquartile range). p-values by ANOVA
or Kruskal-Wallis ANOVA for continuous variables and Fisher’s 2-tailed test for categorical
variables. AA: acetylsalicylic acid, ACEI: angiotensin-converting enzyme inhibitors, BMI: body
mass index, CAD, coronary artery disease, GFR, glomerular filtration rate, LDL, low-density
lipoprotein, LV, left ventricular, VEGF: vascular endothelial growth factor.
Table 2
Patient characteristics – angiographic data
CAD CAD p
normal diastolic impaired
LV function LV relaxation
(n = 16) (n = 14)
Type of vessel involved
LAD/LCX/RCA 8/2/6 7/2/5
% 50/12.5/37.5 50/14/36 NS
Maximal coronary stenosis (%) 88 ± 11 87 ± 10 NS
At least one additional stenosis of 50%
in the same coronary artery territory % 4 (25) 5 (36) NS
Data are shown as means ± SD or n (%). p-values by unpaired Student’s 2-sided t-test
for continuous variables or Fisher’s 2-tailed test for proportions. LAD: left anterior
descending coronary artery, LCX: left circumflex coronary artery, RCA: right coronary
artery.
acteristics (Tables 1 and 2).
CAD subjects with impaired LV relaxation exhibited
a significantly longer IVRT and mitral E wave DT, a
decreased E/A ratio as well as lower indices of relax-
ation by TDI, E’ and E’/A’ ratio, with the reference to
the 2 remaining groups (Table 3; Fig. 1). EF, LVMI and
parameters reflecting LV filling pressures, LAVI and
E/E’ ratio, were similar across the 3 groups (Table 3;
Fig. 1). As compared to CAD subjects with normal LV
diastolic function, CAD patients with impaired LV re-
laxation exhibited significant decreases in exercise du-
ration, maximal workload achieved, time to onset a 0.1-
mV ST segment depression and Duke treadmill score
as well as higher maximal ST segment displacements
(Table 4).
3.2. Intergroup comparisons of NT-proBNP levels
and CD34+/KDR+ cells counts
With the reference to the non-CAD controls (46 [28–
120] pg/ml), NT-proBNP levels were significantly el-
evated in CAD subjects (135 [79–366] pg/ml), which
was more pronounced in those with impaired LV relax-
ation (274 [137–423] pg/ml) relative to a subgroup with
regular diastolic function (99 [59–178] pg/ml) (Fig. 2).
Additionally, in the presence of abnormal LV relax-
ation CD34+/KDR+ cells counts were significantly
decreased (0.025 [0.02–0.03] %) as compared to the
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Table 3
Patient characteristics – echocardiographic data
Non-CAD CAD CAD p
controls normal diastolic impaired ANOVA
(n = 14) LV function LV relaxation
(n = 16) (n = 14)
EF (%) 71 ± 6 73 ± 5 71 ± 8 NS
LVMI (g/m2) 98 ± 21 97 ± 18 100 ± 22 NS
LAVI (ml/m2) 22.5 ± 4.3 22.8 ± 3.8 23.5 ± 3.3 NS
IVRT (ms) 87 ± 15 86 ± 17 121 ± 22** < 0.001
Mitral E wave DT (ms) 192 ± 43 201 ± 39 254 ± 40* < 0.001
E/A ratio 1.4 ± 0.3 1.4 ± 0.4 0.7 ± 0.3** < 0.001
E’ (cm/s) 11.0 ± 2.3 10.7 ± 2.0 5.3 ± 2.1** < 0.001
E’/A’ ratio 1.4 ± 0.3 1.5 ± 0.4 0.7 ± 0.2** < 0.001
E/E’ ratio 7.7 ±2.0 8.0 ±1.8 8.2 ± 2.3 NS
Sm (cm/s) 8.9 ± 1.6 9.2 ± 1.7 8.7 ± 1.5 NS
Data are shown as means ± SD. *p < 0.01, **p < 0.001 vs. CAD subjects with normal
diastolic function and non-CAD controls by the Tukey’s post-hoc test. CAD: coronary
artery disease, DT: deceleration time, E: peak early diastolic mitral inflow velocity,
EF: ejection fraction, E’: peak early diastolic myocardial lengthening velocity at the
junction of the LV lateral wall with the mitral annulus, E’/A’: the ratio of early-to-late
peak diastolic myocardial lengthening velocities, IVRT: isovolumic LV relaxation time,
LAVI: left atrial volume index, LV: left ventricular, LVMI: left ventricular mass index,
Sm: peak systolic myocardial lengthening velocity at the junction of the LV lateral wall
with the mitral annulus.
Table 4
CAD patients – exercise testing results
CAD CAD p
normal diastolic impaired
LV function LV relaxation
(n = 16) (n = 14)
Exercise duration (min) 5.3 ± 1.3 4.4 ± 1.1 0.05
Maximal workload achieved (METs) 6.2 ± 1.4 5.1 ± 1.3 0.03
Time to 0.1-mV ST depression (min) 3.8 ± 1.0 3.0 ± 0.8 0.02
Maximal ST depression in any lead (mV) 0.19 ± 0.03 0.22 ± 0.04 0.04
Exertional chest pain (%) 6 (37.5) 8 (57) NS
Duke treadmill score –5.2 ± 2.7 –7.8 ± 2.3 0.008
Data are shown as means ± SD or n (%). Intergroup p-values by the unpaired Student’s
2-sided t-test. CAD: coronary artery disease, LV: left ventricular, METs: metabolic
equivalents.
Fig. 1. Intergroup comparisons of tissue Doppler indices of LV diastolic function (means ± SD) in CAD subjects with (solid bars) or without
(hatched bars) impaired LV relaxation and non-CAD controls (empty bars): E’ (p < 0.001 by ANOVA) and E/E’ ratio (p > 0.5 by ANOVA).
*p < 0.001 vs. controls and CAD subjects with normal diastolic function by the Tukey’s post-hoc test. Abbreviations as in Table 2.
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Table 5
CAD subjects – correlates of NT-proBNP level and CD34+/KDR+ cells count
NT-proBNP level CD34+/KDR+ cells count
rho p rho p
Age 0.20 NS 0.09 NS
GFR −0.29 0.12 0.30 0.11
LDL cholesterol −0.03 NS −0.07 NS
Fasting glucose 0.06 NS −0.15 NS
High-sensitivity C-reactive protein 0.04 NS 0.01 NS
Left ventricular EF −0.10 NS 0.05 NS
Left ventricular mass index 0.01 NS 0.04 NS
Left atrial volume index 0.22 NS −0.05 NS
Heart rate 0.12 NS −0.02 NS
E’ −0.46 0.01 0.40 0.03
E’/A’ ratio −0.49 0.006 0.43 0.02
E/E’ ratio 0.29 0.12 −0.11 NS
Exercise duration −0.31 0.10 0.27 0.15
Maximal workload achieved −0.33 0.07 0.24 NS
Time to 0.1-mV ST depression −0.40 0.03 0.25 NS
Max. ST depression in any lead 0.24 NS −0.38 0.04
Duke treadmill score −0.58 < 0.001 0.52 0.003
Maximal coronary stenosis 0.05 NS 0.07 NS
Additional 1 stenoses of 50% 0.14 NS −0.10 NS
Calcium channel blockers −0.04 NS 0.08 NS
rho: Spearman’s rank order correlation coefficient; other abbreviations as in Tables 1 and 3.
Fig. 2. NT-proBNP levels (medians and interquartile ranges) in CAD subjects with or without impaired LV relaxation (IR) and non-CAD controls.
Pairwise p-values refer to the Mann-Whitney U test (p = 0.005 by the Kruskal-Wallis ANOVA).
non-CAD control group (0.05 [0.04–0.08]%) and CAD
subjects with regular diastolic function (0.045 [0.035–
0.05] %) (Fig. 3).
3.3. Correlates of NT-proBNP levels and
CD34+/KDR+ cells counts
In CAD patients NT-proBNP concentrations corre-
lated modestly to E’ and E’/A’, whereas weakly to GFR
and E/E’ ratio (Table 5). CD34+/KDR+ cells counts
were modestly correlated with E’ and E’/A’ ratio, and
weakly with GFR. Weak correlations were found be-
tween NT-proBNP and CD34+/KDR+ cells numbers
versus parameters derived from the ECG exercise test,
except for the Duke treadmill score that strongly cor-
related with both these variables (Table 5). The Duke
treadmill score was the only variable which entered
final regression equations describing log-transformed
NT-proBNP levels (β = –0.54 ± 0.15, p = 0.001, ad-
justed R2 = 0.29) or CD34+/KDR+ cells counts (β =
0.46 ± 0.16, p = 0.007, adjusted R2 = 0.20) in CAD
patients.
NT-proBNP levels and CD34+/KDR+ cells num-
bers were inversely correlated in CAD subjects: rho =
–0.48, p = 0.007 for untransformed data (Fig. 4A); r =
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Table 6
Coincidence of elevated NT-proBNP levels and depressed CD34+/KDR+ cells counts in the CAD
patients with a Duke treadmill score below the median (< –6.7)
NT-proBNP (pg/ml) CD34+/KDR+ cells (%)
> 135 < 135 > 0.03  0.03
Duke treadmill score < –6.7 (n = 15) 12 (80%) 3 (20%) 4 (27%) 11 (73%)
Duke treadmill score > –6.7 (n = 15) 3 (20%) 12 (80%) 10 (67%) 5 (33%)
p-value by the Fisher’s test 0.003 0.035
Numbers of patients and respective percentages (in parentheses) have been shown.
Fig. 3. CD34+/KDR+ cells counts (medians and interquartile ranges) in CAD patients with or without impaired LV relaxation (IR) and non-CAD
controls. Pairwise p-values refer to the Mann-Whitney U test (p = 0.003 by the Kruskal-Wallis ANOVA). PBMC: peripheral blood mononuclear
cells.
–0.42, p = 0.02 for log-transformed values. This was
mainly due to the clustering of increased NT-proBNP
and decreased CD34+/KDR+ cells at a low Duke
treadmill score (Fig. 4A). Out of 15 patients with the
treadmill score below the median (< –6.7), 12 subjects
(80%) exhibited NT-proBNP levels over the median (>
135 pg/ml) and in 11 subjects (73%) CD34+/KDR+
cells counts did not exceed the respective median (
0.03 %) (Table 6). The importance of the Duke tread-
mill score for the coincidence of elevated NT-proBNP
and decreased CD34+/KDR+ cells counts was con-
firmed by multiple regression. When both Duke tread-
mill score and log (NT-proBNP) were forced into the
multiple regression equation with a log-derivative of
CD34+/KDR+ cells numbers as a dependent variable
(adjusted R2 = 0.32, p < 0.002), the effect of the
treadmill score was maintained (β = 0.43 ± 0.16, p =
0.01), whereas that of NT-proBNP lost its significance
(β = –0.23 ± 0.16, p = 0.2).
In the non-CAD controls no association between NT-
proBNP concentrations and CD34+/KDR+ cells num-
bers was found: rho = 0.10, p > 0.7 for untransformed
data (Fig. 4B); r = 0.21, p > 0.4 for log-transformed
values. NT-proBNP tended to correlate weakly with
age (r = 0.42, p = 0.13) and GFR (r = –0.40, p =
0.15).
4. Discussion
In our small observational study stable angina pa-
tients with preserved EF and one-vessel obstructive
CAD exhibited higher plasma NT-proBNP levels, espe-
cially at impaired LV relaxation but also at normal LV
diastolic function by conventional indices and TDI. Ad-
ditionally, a significantly lower CD34+/KDR+ cells
blood count was observed in the presence of impaired
relaxation associated with a more pronounced ischemic
burden.
As early as in 1980 Hirota [12] described a prolonged
time constant of LV pressure decay during isovolumic
relaxation in stable angina with normal LV systolic
function. The importance of a decreased coronary flow
reserve for LV relaxation was also confirmed by Bonow
et al. [38] who demonstrated an improvement in LV ear-
ly filling at rest after successful coronary angioplasty in
one-vessel CAD. Importantly, our CAD patients with
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Fig. 4. (A, upper panel): A negative correlation between
CD34+/KDR+ cells counts and NT-proBNP levels in 30 CAD pa-
tients with Duke treadmill score below the median (< –6.7) (closed
circles) or over the median (> –6.7) (open circles). (B, lower pan-
el): The lack of association between CD34+/KDR+ cells counts
and NT-proBNP levels in 14 non-CAD controls (open triangles).
rho: Spearman’s rank order correlation coefficient, PBMC: periph-
eral blood mononuclear cells.
abnormal LV relaxation exhibited a more pronounced
ischemic response to exercise. Finally, Duke tread-
mill score, a prognostic parameter reflecting ischemic
burden at stress testing [35], was a stronger correlate
of both augmented NT-proBNP levels and depressed
CD34+/KDR+ cells numbers than indices of diastolic
function which were eliminated by stepwise multiple
regression. Additionally, adjustment for the treadmill
score abolished the NT-proBNP–CD34+/KDR+ cells
relationship. Accordingly, an as yet unidentified fac-
tor, possibly related to different clinical characteristics
or ischemia by itself, might have mediated the coinci-
dence of a high NT-proBNP and CD34+/KDR+ cells
deficiency in symptomatic stable CAD with impaired
LV relaxation.
4.1. Covariates of potential influence on NT-proBNP
and CD34+/KDR+ cells numbers
Admittedly, we are not able to fully exclude potential
alternative mechanisms that might have been responsi-
ble for the observed relationships. However, a wide set
of exclusion criteria has allowed to eliminate at least
some of factors which might affect CD34+/KDR+
cells counts and/or NT-proBNP levels [24,25,38–41].
These included heart failure, depressed EF, chronic
kidney disease and pulmonary disease. Additionally,
there were no significant intergroup differences in age,
prevalence of hypertension and smoking habit, GFR,
BMI and EF. Second, all subjects in the 3 groups were
treated with statins (known to stimulate EPC mobiliza-
tion [42]) and ACEI, reported to lower BNP levels [39]
and EPC counts [43]. Third, both CAD subgroups ex-
hibited one-vessel CAD and no significant differences
in the type of vessel involved, whereas angiographic
CAD parameters had also been reported to affect B-
type natriuretic peptide levels [1,3,6] and EPC num-
bers [25].
Moreover, not only EF, but also parameters reflecting
LV filling pressure (E/E’ ratio and LAVI) were compa-
rable in the 3 groups, which indicates that factors other
than intergroup differences in LVEDP, a parameter re-
lated to NT-proBNP [44], were responsible for a higher
NT-proBNP in CAD. We cannot however exclude the
possibility that at elevated heart rates and consequent
shortening of the diastole, i.e. during daily physical ac-
tivity, subjects with the impaired LV relaxation pattern
could develop elevated filling pressures and subsequent
elevations of NT-proBNP, whose half-life in plasma is
about 2 h, which might have affected its values mea-
sured at rest. Nevertheless, this appears an unlikely
cause of increased NT-proBNP as blood sampling was
performed after overnight fast and LAVI, a more sta-
ble index of LV filling pressures, was comparable in
the 3 groups. Additionally, in the presence of abnor-
mal LV relaxation 3–6 fold elevations of baseline B-
type natriuretic peptides levels were demonstrated [8,
10], including BNP [10], whose half-life is only about
18 min [39].
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4.2. Exercise-induced ischemia versus B-type
natriuretic peptides in stable angina
Although in the studies relating BNP/NT-proBNP
to isolated diastolic dysfunction CAD was present in
41–50% of subjects [8,10], quantitative parameters of
ischemia during stress testing were not reported. Fur-
thermore, among the studies that have revealed that
baseline elevations of B-type natriuretic peptides are
more pronounced in CAD patients with inducible is-
chemia on cardiac stress imaging compared to those
with negative test results [45–51], indices of LV dias-
tolic function were provided exclusively by the Heart
and Soul Study Investigators [49,50]. The relation-
ship between BNP/NT-proBNP and inducible ischemia
has been demonstrated irrespective of imaging tech-
nique for nuclear perfusion imaging [45–48], exercise
echocardiography [49,50] and dobutamine echocardio-
graphy [51]. Moreover, the role of the ischemic stim-
ulus for NT-proBNP elevation in stable angina is sup-
ported by falls in the peptide level after elective angio-
plasty [52].
In the present study NT-proBNP correlated to both
TDI indices of impaired LV relaxation at rest and pa-
rameters related to exercise-induced ischemia, never-
theless, Duke treadmill score was the sole multivariate
determinant of NT-proBNP. Additionally, in our hands,
NT-proBNP levels were elevated also in stable angina
subjects with a normal LV relaxation pattern. There-
fore it appears probable that a higher NT-proBNP con-
centration in our patients was attributable to repetitive
ischemic episodes in their daily life. This concept had
been put forward by Bibbins-Domingo et al. [49] on the
basis of data of 355 Heart and Soul Study patients to ex-
plain elevated BNP at rest in stable CAD subjects with
inducible myocardial ischemia, which was only slight-
ly attenuated after adjustment for EF and echocardio-
graphic categories of diastolic dysfunction. Moreover,
in all 901 participants of the Heart and Soul Study [50],
the relationship between NT-proBNP and inducible is-
chemia was limited to the patients with an EF > 50%
and either normal diastolic function or impaired LV re-
laxation pattern, i.e. similar to our CAD subjects. This
indicates that the NT-proBNP – ischemia relationship
can be more easily detectable in the absence of coex-
istent abnormalities obscuring the association, such as
systolic LV dysfunction or advanced diastolic dysfunc-
tion with consecutive markedly increased NT-proBNP
levels.
As suggested by Tateishi et al. [53], BNP release in
hypoxic conditions might be partially independent of
LV diastolic dysfunction as hemodynamic parameters
were not related to transient rises in BNP in response
to ischemia during balloon inflation at coronary angio-
plasty. Mechanistically, in stable angina patients with-
out LV systolic dysfunction undergoing surgical revas-
cularization, Goetze et al. [11] have shown augment-
ed expression of BNP gene in hypoxic ventricular my-
ocardium that correlated with several-fold elevations
of plasma BNP (5-fold) and NT-pro-BNP (8–10-fold)
levels. Hopkins and colleagues [54] demonstrated that
chronic hypoxia was responsible for 12-fold elevations
of NT-proBNP concentrations in cyanotic congenital
heart disease despite low right atrial pressures. Final-
ly, a hypoxia-inducible factor-1-responsiveelement has
been identified in the BNP promoter [55].
4.3. Exercise-induced ischemia versus
CD34+/KDR+ cells counts in stable angina
Hypoxia-inducible factor-1 activates the expression
of VEGF [56], a potent mediator stimulating mobiliza-
tion of EPC from the bone marrow into the blood. This
was a likely explanation of an over 3-fold increase in
circulating EPC number in response to a single episode
of myocardial ischemia, which reached its maximum
24 h after exercise and persisted until 48 h, being cor-
related exclusively to the preceding augmented release
of VEGF (2–6 h after exercise) [26]. Moreover, this
effect was similar with cells quantification by means of
both flow cytometric analysis (CD34+/KDR+ cells)
and the EPC in vitro culture assay [26]. Therefore, a se-
lective depression of the CD34+/KDR+ cells count in
our angina CCS class III patients with impaired LV re-
laxation was rather a surprising phenomenon, because
they exhibited a shorter time to ischemic ST segment
depression than those with normal relaxation pattern,
which could precipitate repetitive ischemic episodes at
a normal activity.
In search for a possible explanation, we hypothe-
size that an eventual exhaustion of the bone marrow
capacity to mobilize EPC might have occurred in CAD
patients exposed to multiple ischemic episodes during
daily life. This hypothesis is analogous to that put
forward by Fadini et al. [57] who observed a lower
CD34+/KDR+ cells count in advanced lung disease
and long-lasting hypoxia and suggested that the contin-
uous hypoxic stimulation might had led to an exhaus-
tion of the bone marrow precursor pool of EPC.
As an alternative mechanism, keeping in mind the
previously reported independent relationship between
coronary endothelial dysfunction and CD34+/KDR+
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Fig. 5. The magnitude of ischemic burden as a hypothetical common mechanism underlying both elevated plasma NT-proBNP levels and
circulating CD34+/KDR+ cells deficiency in stable angina CAD patients with impaired LV relaxation.
cells deficiency in stable CAD [20], it could be also
proposed that lower CD34+/KDR+ cells counts might
predispose to exertional myocardial ischemia via local
endothelial dysfunction with consequent impairment of
coronary flow reserve. In fact, Zeiher et al. [58] had
demonstrated that coronary microvascular endothelial
dysfunction translated into exercise-induced myocar-
dial ischemia by nuclear perfusion imaging. These
two hypothetical concepts are not mutually exclusive
because endothelial dysfunction could exacerbate my-
ocardial ischemia [58], which, in turn, may exacer-
bate CD34+/KDR+ cells deficiency through the for-
mer mechanism.
4.4. B-type natriuretic peptides versus
hematopoietic/endothelial progenitor cells and
endothelial function
Irrespective of the mechanism involved, CD34+/
KDR+ cells deficiency in patients with stable angi-
na and impaired LV relaxation adds into a broad set
of abnormalities associated with excessive secretion
of BNP/NT-proBNP within a so-called “grey zone” of
their levels. Associations between B-type natriuretic
peptides and progenitor cells numbers in blood were
reported in different clinical settings. First, in acute ST-
segment elevation myocardial infarction NT-proBNP
levels and CD34+ hematopoietic progenitor cells, al-
though both elevated, correlated inversely with each
other [59]. Second, in systolic heart failure patients the
numbers of CD34+ and CD34+/CD133+/KDR+ cells
were lower in NYHA classes III–IV associated with
higher BNP levels [40]. Additionally, the amelioration
of decompensated heart failure symptoms was accom-
panied by interrelated decreases in BNP and increases
in CD34+ cells counts [60]. Third, NT-proBNP and
CD34+/CD133+/KDR+ cells counts were inversely
correlated 72 h after cardiac surgery [61].
In a large community-based study of 1,991 subjects
free of heart and renal failure, BNP and NT-proBNP
concentrations predicted risk of death over a median
follow-up of 5.6 years in part independently of clinical
covariates and coexistent echocardiographic abnormal-
ities including lower EF, elevated LV mass, left atri-
al enlargement and, importantly, diastolic dysfunction
categorized by conventional indices and TDI [62]. It
has therefore been proposed that elevated levels of B-
type natriuretic peptides may represent a final com-
mon pathway of a variety of cardiovascular disorders
beyond hemodynamic factors directly related to heart
failure [62]. It cannot be excluded that endothelial dys-
function might also belong to this set of abnormalities.
In line with this concept, Chong et al. [63] observed
an inverse correlation between BNP and flow-mediated
dilation of the brachial artery in stable heart failure pa-
tients, although neither of these parameters was related
to EF or NYHA functional class.
Nevertheless, it is clear that the presence of a cor-
relation does not imply a cause-and-effect relation-
ship. On the basis of the present study we rather sug-
gest that a common factor, probably repetitive ischemic
burden, can be accountable for the coincidence of an
elevated NT-proBNP concentration and a depressed
CD34+/KDR+ cells count in stable angina patients
exhibiting features of impaired LV relaxation (Fig. 5).
112 A. Surdacki et al. / Moderately elevated NT-proBNP and endothelial progenitor cells deficiency versus exertional myocardial ischemia
4.5. Limitations of the study
Admittedly, we have no direct proof in support of
the above proposed hypothetical mechanism of the co-
incidence of high NT-proBNP and low CD34+/KDR+
cells counts. It cannot be excluded that early events in
the ischemic cascade (e.g. subclinical chronic ischemia
owing to joint effects of epicardial stenosis and preex-
isting microvascular dysfunction) might be more rel-
evant for NT-proBNP release than the magnitude of
symptomatic exercise-induced ischemia that was used
for the calculation of Duke treadmill score.
Additionally, it is highly unlikely that BNP could
directly negatively affect EPC mobilization controlled
by a local L-arginine–NO pathway in the bone mar-
row [64]. Moreover, there is evidence that BNP per
se may produce not detrimental but beneficial effects
on endothelial NO generation [65] and EPC mobiliza-
tion [66].
An alternative common mechanism of both high
NT-proBNP and low CD34+/KDR+ cells counts
might be inflammatory activation as suggested recent-
ly by Cesari et al. [61], who ascribed the observed
inverse correlation between NT-proBNP levels and
CD34+/CD133+/KDR+ cells numbers after cardiac
surgery to an altered balance between pro- and anti-
inflammatory cytokines. However we have found no
differences in C-reactive protein, an approximate index
of inflammation, between the 3 groups of our patients.
4.6. Conclusions
Propensity to symptomatic exertional ischemia may
underlie the coincidence between moderately elevated
NT-proBNP and EPC deficiency in patients with stable
CAD. Additionally, chronic subclinical ischemia can
also be involved in these associations. These might
result from BNP overexpression in the ischemic my-
ocardium and a hypothetical exhaustion of the bone
marrow capacity to mobilize EPC in response to mul-
tiple ischemic episodes, thus contributing to the prog-
nostic effect of B-type natriuretic peptides irrespective
of hemodynamic factors.
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